These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 33237353

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Guo S, Qin H, Liu K, Wang H, Bai S, Liu S, Shao Z, Zhang Y, Song B, Xu X, Shen J, Zeng P, Shi X, Chen H, Gao S, Xu J, Pan Y, Xiong L, Li F, Zhang D, Jiao X, Jin G.
    Clin Transl Med; 2021 Sep; 11(9):e520. PubMed ID: 34586739
    [Abstract] [Full Text] [Related]

  • 3. Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma.
    Liu DSK, Puik JR, Patel BY, Venø MT, Vahabi M, Prado MM, Webber JP, Rees E, Upton FM, Bennett K, Blaker C, Immordino B, Comandatore A, Morelli L, Sivakumar S, Swijnenburg RJ, Besselink MG, Jiao LR, Kazemier G, Giovannetti E, Krell J, Frampton AE.
    J Exp Clin Cancer Res; 2024 Jul 08; 43(1):189. PubMed ID: 38978141
    [Abstract] [Full Text] [Related]

  • 4. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.
    Xu X, Bhandari K, Xu C, Morris K, Ding WQ.
    Int J Mol Sci; 2023 Apr 13; 24(8):. PubMed ID: 37108374
    [Abstract] [Full Text] [Related]

  • 5. miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis.
    Li X, Xu H, Yi J, Dong C, Zhang H, Wang Z, Miao L, Zhou W.
    J Cell Mol Med; 2021 May 13; 25(10):4671-4683. PubMed ID: 33811437
    [Abstract] [Full Text] [Related]

  • 6. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
    Nesteruk K, Levink IJM, de Vries E, Visser IJ, Peppelenbosch MP, Cahen DL, Fuhler GM, Bruno MJ.
    Pancreatology; 2022 Jun 13; 22(5):626-635. PubMed ID: 35613957
    [Abstract] [Full Text] [Related]

  • 7. Proteomic analysis distinguishes extracellular vesicles produced by cancerous versus healthy pancreatic organoids.
    Buenafe AC, Dorrell C, Reddy AP, Klimek J, Marks DL.
    Sci Rep; 2022 Mar 03; 12(1):3556. PubMed ID: 35241737
    [Abstract] [Full Text] [Related]

  • 8. PDX-derived organoids model in vivo drug response and secrete biomarkers.
    Huang L, Bockorny B, Paul I, Akshinthala D, Frappart PO, Gandarilla O, Bose A, Sanchez-Gonzalez V, Rouse EE, Lehoux SD, Pandell N, Lim CM, Clohessy JG, Grossman J, Gonzalez R, Del Pino SP, Daaboul G, Sawhney MS, Freedman SD, Kleger A, Cummings RD, Emili A, Muthuswamy LB, Hidalgo M, Muthuswamy SK.
    JCI Insight; 2020 Nov 05; 5(21):. PubMed ID: 32990680
    [Abstract] [Full Text] [Related]

  • 9. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
    Uysal-Onganer P, D'Alessio S, Mortoglou M, Kraev I, Lange S.
    Int J Mol Sci; 2021 Jan 30; 22(3):. PubMed ID: 33573274
    [Abstract] [Full Text] [Related]

  • 10. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells.
    Choi JI, Jang SI, Hong J, Kim CH, Kwon SS, Park JS, Lim JB.
    Cancer Lett; 2021 Feb 01; 498():42-53. PubMed ID: 33188841
    [Abstract] [Full Text] [Related]

  • 11. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
    Li JT, Yin M, Wang D, Wang J, Lei MZ, Zhang Y, Liu Y, Zhang L, Zou SW, Hu LP, Zhang ZG, Wang YP, Wen WY, Lu HJ, Chen ZJ, Su D, Lei QY.
    Nat Cell Biol; 2020 Feb 01; 22(2):167-174. PubMed ID: 32029896
    [Abstract] [Full Text] [Related]

  • 12. Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids.
    LeSavage BL, Zhang D, Huerta-López C, Gilchrist AE, Krajina BA, Karlsson K, Smith AR, Karagyozova K, Klett KC, Huang MS, Long C, Kaber G, Madl CM, Bollyky PL, Curtis C, Kuo CJ, Heilshorn SC.
    Nat Mater; 2024 Aug 01; 23(8):1138-1149. PubMed ID: 38965405
    [Abstract] [Full Text] [Related]

  • 13. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma.
    Koikawa K, Ohuchida K, Ando Y, Kibe S, Nakayama H, Takesue S, Endo S, Abe T, Okumura T, Iwamoto C, Moriyama T, Nakata K, Miyasaka Y, Ohtsuka T, Nagai E, Mizumoto K, Hashizume M, Nakamura M.
    Cancer Lett; 2018 Jul 01; 425():65-77. PubMed ID: 29580808
    [Abstract] [Full Text] [Related]

  • 14. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Helm O, Mennrich R, Petrick D, Goebel L, Freitag-Wolf S, Röder C, Kalthoff H, Röcken C, Sipos B, Kabelitz D, Schäfer H, Oberg HH, Wesch D, Sebens S.
    PLoS One; 2014 Jul 01; 9(5):e94357. PubMed ID: 24797069
    [Abstract] [Full Text] [Related]

  • 15. BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cells.
    Alashkar Alhamwe B, Ponath V, Alhamdan F, Dörsam B, Landwehr C, Linder M, Pauck K, Miethe S, Garn H, Finkernagel F, Brichkina A, Lauth M, Tiwari DK, Buchholz M, Bachurski D, Elmshäuser S, Nist A, Stiewe T, Pogge von Strandmann L, Szymański W, Beutgen V, Graumann J, Teply-Szymanski J, Keber C, Denkert C, Jacob R, Preußer C, Pogge von Strandmann E.
    Cell Mol Immunol; 2024 Aug 01; 21(8):918-931. PubMed ID: 38942797
    [Abstract] [Full Text] [Related]

  • 16. Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs.
    Xu YF, Xu X, Bhandari K, Gin A, Rao CV, Morris KT, Hannafon BN, Ding WQ.
    PLoS One; 2021 Aug 01; 16(11):e0259563. PubMed ID: 34784377
    [Abstract] [Full Text] [Related]

  • 17. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.
    Cote GA, Gore AJ, McElyea SD, Heathers LE, Xu H, Sherman S, Korc M.
    Am J Gastroenterol; 2014 Dec 01; 109(12):1942-52. PubMed ID: 25350767
    [Abstract] [Full Text] [Related]

  • 18. Extracellular vesicles from pancreatic ductal adenocarcinoma endoscopic ultrasound-fine needle aspiration samples contain a protein barcode.
    Inoue H, Eguchi A, Kobayashi Y, Usugi E, Yamada R, Tsuboi J, Akuta T, Horiki N, Iwasa M, Takei Y.
    J Hepatobiliary Pancreat Sci; 2022 Mar 01; 29(3):394-403. PubMed ID: 34555251
    [Abstract] [Full Text] [Related]

  • 19. Esophageal Adenocarcinoma-Derived Extracellular Vesicle MicroRNAs Induce a Neoplastic Phenotype in Gastric Organoids.
    Ke X, Yan R, Sun Z, Cheng Y, Meltzer A, Lu N, Shu X, Wang Z, Huang B, Liu X, Wang Z, Song JH, Ng CK, Ibrahim S, Abraham JM, Shin EJ, He S, Meltzer SJ.
    Neoplasia; 2017 Nov 01; 19(11):941-949. PubMed ID: 28968550
    [Abstract] [Full Text] [Related]

  • 20. Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma.
    Dobre M, Herlea V, Vlăduţ C, Ciocîrlan M, Balaban VD, Constantinescu G, Diculescu M, Milanesi E.
    Cells; 2021 Jul 22; 10(8):. PubMed ID: 34440625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.